Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kalle Hakala"'
Autor:
Ritva Koskela, Clas-Göran af Björkesten, Jyrki Tillonen, Christian Nielsen, M Koivunen, Erkki Soini, Taru Hallinen, Ilkka Vihriälä, Airi Jussila, Ulla-Maija Suhonen, C Wennerström, Karri T Utriainen, Inka Koskinen, Kalle Hakala, R Nissinen, Tuire Ilus, Andras Borsi, Heikki Nuutinen, Markku Heikkinen, Veikko Moilanen, Taina Sipponen, Urpo Nieminen, Anja Eberl, Mikko Heikura
Publikováno v:
European Journal of Gastroenterology & Hepatology
Objective: Long-term evidence on ustekinumab treatment response and persistence in patients with Crohn’s disease in a real-world setting is scarce. We performed a retrospective nationwide chart review study of long-term clinical outcomes in Crohn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b08958ca35c5309464a06db3202fb6ef
https://doi.org/10.1097/meg.0000000000001831
https://doi.org/10.1097/meg.0000000000001831
Autor:
Ilkka Vihriälä, Jari Punkkinen, Tero Ylisaukko-oja, Taina Sipponen, Eija Hirsi, Christian Nielsen, Jyrki Tillonen, Markku Pajala, Jouni Silvennoinen, Ville Liukkonen, Mikko Kellokumpu, Jari Jokelainen, Henna Rautiainen, Veikko Moilanen, Hans Henricson, Hannu Sulonen, Mirva Esterinen, Timo Blomster, Kari Toljamo, Klaus Tamminen, Pauliina Molander, Airi Jussila, Jaakko Aaltonen, Juha Kuisma, Petri Mäkelä, Kalle Hakala, Margus Lääne, Kimmo Salminen, Sauli Herrala, Ulla-Maija Suhonen, Mika Puhto, Markku Peräaho, Heikki Nuutinen
Publikováno v:
Scandinavian Journal of Gastroenterology. 53:158-167
Objectives: The efficacy and tolerability of vedolizumab in the treatment of inflammatory bowel diseases (IBD) has been demonstrated in an extensive GEMINI clinical trial programme. Clinical trials represent highly selected patient populations and, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9bb6f87c8c3b92c84b454447a30170
https://doi.org/10.1080/00365521.2017.1416160
https://doi.org/10.1080/00365521.2017.1416160
Autor:
Kalle Hakala, C Wennerström, Eija Hirsi, Moilanen, Mikko Heikura, Ilkka Vihriälä, Jyrki Tillonen, C G af Björkesten, Karri T Utriainen, Taru Hallinen, Urpo Nieminen, Heikki Nuutinen, Tuire Ilus, Ulla-Maija Suhonen, Erkki Soini, Ritva Koskela, Mikko Kellokumpu, Airi Jussila, Christian Nielsen, Anja Eberl, Inka Koskinen, Andras Borsi, R Nissinen, Taina Sipponen, Markku Heikkinen, M Koivunen
Publikováno v:
Journal of Crohn's and Colitis. 14:S434-S435
Background Real-life long-term evidence on ustekinumab treatment response in patients with Crohn’s disease (CD) is scarce. We performed a retrospective non-interventional nationwide chart review study of dosing and long-term clinical outcomes in Fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32b806415ff67d89e888beede7fd909d
https://doi.org/10.1093/ecco-jcc/jjz203.628
https://doi.org/10.1093/ecco-jcc/jjz203.628
Autor:
Ritva Koskela, Mikko Kellokumpu, Mikko Heikura, Taru Hallinen, Christian Nielsen, C Wennerström, Urpo Nieminen, M Koivunen, Inka Koskinen, Ilkka Vihriälä, C G af Björkesten, Kalle Hakala, Eija Hirsi, Anja Eberl, Erkki Soini, Jyrki Tillonen, R Nissinen, Ulla-Maija Suhonen, Taina Sipponen, Tuire Ilus, Veikko Moilanen, Andras Borsi, Heikki Nuutinen, Markku Heikkinen, Karri T Utriainen, Airi Jussila
Publikováno v:
Journal of Crohn's and Colitis. 14:S066-S066
Background Real-life long-term evidence on ustekinumab treatment in patients with Crohn’s disease (CD) is limited. We performed a retrospective non-interventional nation-wide chart review study of dosing and long-term clinical outcomes in Finnish C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b679397501d4d9d1f07d8a9e44045e3d
https://doi.org/10.1093/ecco-jcc/jjz203.065
https://doi.org/10.1093/ecco-jcc/jjz203.065
Autor:
Klaus Tamminen, Mikko Kellokumpu, Tero Ylisaukko-oja, Sauli Herrala, Markku Peräaho, Taina Sipponen, Henna Rautiainen, Petri Mäkelä, Jari Jokelainen, Ulla-Maija Suhonen, Heikki Nuutinen, Markku Pajala, Mirva Esterinen, Margus Lääne, Mika Puhto, Christian Nielsen, Jyrki Tillonen, Veikko Moilanen, Juha Kuisma, Ville Liukkonen, Kalle Hakala, Pauliina Molander, Hannu Sulonen, Saku Torvinen, Jaakko Aaltonen, Jouni Silvennoinen, Hans Henricson, Ilkka Vihriälä, Eija Hirsi, Kari Toljamo, Airi Jussila, Jari Punkkinen, Timo Blomster, Kimmo Salminen
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization. 58
Limited data is available on vedolizumab combination therapies in real-world clinical practice. Here, we evaluated the concomitant corticosteroid, immunosuppressive, and 5-aminosalicylic acid utilization of inflammatory bowel disease (IBD) patients t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e3e084581707aa9c9a3ddfb0c44882
https://pubmed.ncbi.nlm.nih.gov/30755369
https://pubmed.ncbi.nlm.nih.gov/30755369
Publikováno v:
Gut. 41:771-777
Background—No data exist on cholesterol absorption in patients with an ileoanal anastomosis (IAA).Aims—To study cholesterol absorption and its effects on cholesterol and bile acid metabolism in patients with an IAA.Patients and methods—Choleste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0dfa1818202a9f45548d1ebba25371f
https://doi.org/10.1136/gut.41.6.771
https://doi.org/10.1136/gut.41.6.771
Publikováno v:
Journal of Hepatology. 26:1306-1312
Background: Previous studies suggest only minor changes in bile acid metabolism after panproctocolectomy with ileal pouch construction. Aims/Methods: To investigate these changes further, we studied cholesterol absorption and serum, biliary and fecal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9814c2456bc5b91455d906d01b64b7
https://doi.org/10.1016/s0168-8278(97)80466-7
https://doi.org/10.1016/s0168-8278(97)80466-7
Serum Cholestanol, Cholesterol Precursors and Plant Sterols in Different Inflammatory Bowel Diseases
Publikováno v:
Digestion. 57:83-89
The role of cholestasis and ileal dysfunction on sterol metabolism was studied in 79 patients with inflammatory bowel diseases (IBDs) and in 23 irritable bowel syndrome (IBS) controls by determining serum sterol/cholesterol proportions. The sterols i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb51f4bdd8e016aeaf36d8c95887db97
https://doi.org/10.1159/000201318
https://doi.org/10.1159/000201318
Autor:
Ulla Turunen, Kalle Hakala, Matti Vuoristo, Martti Färkkilä, Ville Valtonen, Mats Ögren, K. Seppälä, Tatu A. Miettinen, Aulikki Sivonen
Publikováno v:
Gastroenterology. 115(5)
Background & Aims: Although bacterial bowel flora may be one of the contributing factors in the pathogenesis of chronic mucosal inflammation, antibiotic treatment has no established role in ulcerative colitis. The aim of the study was to evaluate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf13cba3c3e7f02f36466b2c2697429
https://pubmed.ncbi.nlm.nih.gov/10428612
https://pubmed.ncbi.nlm.nih.gov/10428612